RSPIRespireRx Pharmaceuticals Inc.
Price Chart
Loading chart...
About RespireRx Pharmaceuticals Inc. (RSPI)
RespireRx Pharmaceuticals Inc. (RSPI) is a Biotechnology company headquartered in Glen Rock, NJ, United States whose shares trade over-the-counter on the Expert Market tier.
RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions.
Products and services
The Company is engaged in research and development of pharmaceutical products and does not have principal products.
RSPI key facts
- Ticker symbol
- RSPI
- Market tier
- Expert Market
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Glen Rock, NJ, United States
- Country of incorporation
- US
- Year of incorporation
- 1987
- Employees
- 2
- Estimated market cap
- $759.6K (as of Apr 11, 2025)
- Shares outstanding
- 949,463,730
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 12/31
- Latest filing
- 8K Report (Jan 18, 2024)
RespireRx Pharmaceuticals Inc. leadership
- Jeff E. Margolis — CFO, Senior VP, Secretary
- David Dickason — SVP, Product Dev.
- Richard D. Purcell, Jr. — SVP, R&D
- Arnold S. Lippa — CSO, Interim CEO
Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with R
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for RespireRx Pharmaceuticals Inc. (RSPI) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...